DiseasesIrritable bowel syndrome—is diet and stress to blame?
- Henryk Różański — Gluten w pożywieniu
- Hubert Czerniak — Maślan Sodu - Polecam sklep E-Remedium
- Piotr Witczak — Holistyczny Program Odnowy Organizmu
- Henryk Różański — Zaburzenia gospodarki magnezowej.
- Irritable bowel syndrome - from etiopathogenesis to therapy. · Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2018
- Irritable bowel syndrome and diet. · Gastroenterol Rep (Oxf) 2017
- The Potential of Complementary and Alternative Therapies in Improving Diarrhea-Predominant Irritable Bowel Syndrome: Strategies for Long-Term Efficacy. · Dig Dis Sci 2026
- Effectiveness of a FODMAP-Based, Coach-Supervised, and Peer-Supported Lifestyle Program in Reducing Gastrointestinal and Extraintestinal Symptoms in Irritable Bowel Syndrome. · Gastro Hep Adv 2026
- Orthomolecular Medicine News Service — Seven Arguments for Taking Nutritional Supplements
- Orthomolecular Medicine News Service — Rethinking Plant-Based Nutrition: The Hidden Costs Behind the Greens and Fruits
- Orthomolecular Medicine News Service — Benign Prostatic Hyperplasia (BPH): Saw Palmetto and other dietary factors can help
Henryk Różański recommends low-gluten or gluten-free foods for people with irritable bowel syndrome.
- He points out that gluten may slow the passage of food and make digestion more difficult.
- Hubert Czerniak classifies this syndrome as a mild inflammation and writes that sodium butyrate may reduce inflammation.
- Piotr Witczak mentions a possible link between the syndrome and chronic heavy metal poisoning, while Różański links stress with magnesium deficiency.
What the authors write
Henryk Różański recommends low-gluten or gluten-free foods for people with irritable bowel syndrome and points out that gluten may slow the passage of food and make digestion more difficult.
Hubert Czerniak classifies irritable bowel syndrome as a mild inflammation and writes that sodium butyrate may help with these conditions by reducing inflammation.
Piotr Witczak lists irritable bowel syndrome among the diseases that may be linked to chronic heavy metal poisoning.
Henryk Różański lists stressful conditions and long-term depression as possible causes of magnesium deficiency, but does not identify them as causes of irritable bowel syndrome.
Research from PubMed · Europe PMC
We selected 4 studies with the best, positive results. This is a selection, not a full review of all research.
Total number of studies on this topic in PubMed: 189.
The review reports that emotional stress and eating may worsen IBS symptoms.
Aim of the study: Irritable bowel syndrome (IBS) is a chronic and relapsing functional gastrointestinal disorder that affects 9-23% of the population across the world. Patients with IBS are often referred to gastroenterology, undergo various investigations, take various medicines, take time off work and have a poor quality of life.
Results: Today the Rome Criteria IV is the current gold-standard for the diagnoses of IBS. Treatment of patients with IBS requires a multidisciplinary approach. Some patients respond well to non-pharmacological treatment, while others also require pharmacological treatment. This review will provide a summary of pathophysiology, diagnostic criteria and therapies for IBS.
“Not stated” does not mean nobody paid — the database does not always record it.
The review indicates that a diet with limited FODMAP content may be a helpful approach for IBS.
Aim of the study: Irritable bowel syndrome (IBS) is a chronic functional disorder of the gastrointestinal tract and is one of the most commonly diagnosed gastrointestinal diseases. The impact of IBS on the general population is large due to its high prevalence, suboptimal medical treatments and significant economic burden.
Results: The most common therapeutic approaches for IBS include education and reassurance, lifestyles (especially nutrition-based interventions), peripherally acting medications (which typically target motility), centrally acting medications (which target visceral hypersensitivity and pain) and psychological interventions (which aim to reduce the effects of stress or symptom-specific anxiety). A beneficial dietary approach might include the following measures: a diet low in fermentable oligo-,di- and monosaccharides and polyols (FODMAPs), limitation or exclusion of gas-producing foods and/or lactose and gluten and fiber supplementation in selected cases. New therapeutic agents, namely nutraceutics, are also an interesting option in the management of IBS patients. This paper will focus on available dietary interventions for IBS and will review the evidence for nutrition-based therapies.
“Not stated” does not mean nobody paid — the database does not always record it.
The review indicates that dietary interventions may provide long-lasting relief from diarrhea and abdominal pain in IBS-D.
Aim of the study: Diarrhea-predominant irritable bowel syndrome (IBS-D) is a common disorder of gut-brain interaction. Current therapeutic approaches frequently fail to provide sustained symptom relief.
Results: The findings suggest that traditional Chinese medicine, acupuncture, and dietary interventions can provide sustained relief from core symptoms of IBS-D, including diarrhea and abdominal pain. Their therapeutic effects are mediated through multiple mechanisms, including modulation of the gut microbiota and its metabolites, restoration of intestinal mucosal barrier integrity, attenuation of visceral hypersensitivity, and regulation of the gut-brain axis. These therapies exhibit multi-target and systemic effects with a low incidence of adverse events, highlighting their promising clinical potential. They offer feasible strategies for achieving long-term remission and facilitating personalized management of IBS-D.
“Not stated” does not mean nobody paid — the database does not always record it.
After a three-week program combining a low-FODMAP diet with behavioral support, the severity of IBS and depression symptoms decreased.
Aim of the study: We aimed to evaluate the impact of a comprehensive lifestyle program that integrates dietary, behavioral, and peer support strategies on gastrointestinal and extraintestinal symptoms in patients with irritable bowel syndrome (IBS).
Results: A total of 14,186 patients with IBS were analyzed; the mean age was 44.5 (16-86) years, and 13,323 (93.9%) were female. IBS-M (mixed bowel habits) was the more frequent IBS subtype (n = 6,496, 45.8%); 8729 (61.5%) had ≥2 extraintestinal symptoms, and 6923 (48.8%) reported moderate or severe depressive symptoms. IBS-Severity Scoring System scores significantly decreased from 287.3 ± 69.5 to 188.3 ± 87.6 (P < .001), and Patient Health Questionnaire-9 scores improved from 10.2 ± 5.4 to 3.6 ± 3.4 (P < .001). All extraintestinal symptom scores showed significant reductions (P < .001), and 5540/8729 (63.5%) and 8403/11,746 (71.5%) reported >50% reduction of intensity in at least 2 extraintestinal digestive and non-digestive symptoms, respectively. A structured multidisciplinary intervention with dietary guidance and non-pharmacological strategies significantly improved both gastrointestinal and extraintestinal symptoms of IBS.
“Not stated” does not mean nobody paid — the database does not always record it.
Perspectives and opinion materials
The content below presents the authors’ opinions, interpretations and hypotheses. It is not treated as equal to scientific studies and systematic reviews.
Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.